Cargando…

Protease-dependent defects in N-cadherin processing drive PMM2-CDG pathogenesis

The genetic bases for the congenital disorders of glycosylation (CDG) continue to expand, but how glycosylation defects cause patient phenotypes remains largely unknown. Here, we combined developmental phenotyping and biochemical studies in a potentially new zebrafish model (pmm2(sa10150)) of PMM2-C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klaver, Elsenoor J., Dukes-Rimsky, Lynn, Kumar, Brijesh, Xia, Zhi-Jie, Dang, Tammie, Lehrman, Mark A., Angel, Peggi, Drake, Richard R., Freeze, Hudson H., Steet, Richard, Flanagan-Steet, Heather
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783681/ https://www.ncbi.nlm.nih.gov/pubmed/34784297 http://dx.doi.org/10.1172/jci.insight.153474

Ejemplares similares

A zebrafish model of PMM2-CDG reveals altered neurogenesis and a substrate-accumulation mechanism for N-linked glycosylation deficiency
por: Cline, Abigail, et al.
Publicado: (2012)

Selective inhibition of N-linked glycosylation impairs receptor tyrosine kinase processing
por: Klaver, Elsenoor, et al.
Publicado: (2019)

Spontaneous improvement of carbohydrate-deficient transferrin in PMM2-CDG without mannose observed in CDG natural history study
por: Witters, Peter, et al.
Publicado: (2021)

Mannose supplementation in PMM2-CDG
por: Taday, Roman, et al.
Publicado: (2021)

Anthropometric Phenotype of Patients with PMM2-CDG
por: Lipiński, Patryk, et al.
Publicado: (2021)

Genotype-Phenotype Correlations in PMM2-CDG
por: Vaes, Laurien, et al.
Publicado: (2021)

Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment
por: Serrano, Mercedes, et al.
Publicado: (2015)

Unsuccessful intravenous D-mannose treatment in PMM2-CDG
por: Grünert, Sarah C., et al.
Publicado: (2019)

PMM2‐CDG and nephrotic syndrome: A case report
por: Banderali, Giuseppe, et al.
Publicado: (2022)

Recurrent fetal truncus arteriosus associated with PMM2‐CDG
por: Malheiro, Filipa, et al.
Publicado: (2021)

Interplay of Impaired Cellular Bioenergetics and Autophagy in PMM2-CDG
por: Ligezka, Anna N., et al.
Publicado: (2023)

Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG)
por: Taday, Roman, et al.
Publicado: (2020)

A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation
por: Chu, Jaime, et al.
Publicado: (2013)

Clinical and radiological correlates of activities of daily living in cerebellar atrophy caused by PMM2 mutations (PMM2-CDG)
por: Pettinato, Fabio, et al.
Publicado: (2021)

A Biochemical Platform to Define the Relative Specific Activity of IDUA Variants Identified by Newborn Screening
por: Yu, Seok-Ho, et al.
Publicado: (2020)

GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients
por: de la Morena-Barrio, Maria E, et al.
Publicado: (2013)

PMM2‐CDG caused by uniparental disomy: Case report and literature review
por: Vaes, Laurien, et al.
Publicado: (2020)

The development of end stage renal disease in two patients with PMM2‐CDG
por: Tiwary, Henna, et al.
Publicado: (2022)

Hypoglycemia in CDG patients due to PMM2 mutations: Follow up on hyperinsulinemic patients
por: Moravej, Hossein, et al.
Publicado: (2019)

Upregulation of Sortilin, a Lysosomal Sorting Receptor, Corresponds with Reduced Bioavailability of Latent TGFβ in Mucolipidosis II Cells
por: Barnes, Jarrod W., et al.
Publicado: (2020)

Novel Splicing Variant in the PMM2 Gene in a Patient With PMM2-CDG Syndrome Presenting With Pericardial Effusion: A Case Report
por: Slaba, Katerina, et al.
Publicado: (2020)

Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG)
por: García-López, Roberto, et al.
Publicado: (2016)

Anesthetic management of a child with phosphomannomutase-2 congenital disorder of glycosylation (PMM2-CDG)
por: Sakai, Wataru, et al.
Publicado: (2017)

A quantitative assessment of the evolution of cerebellar syndrome in children with phosphomannomutase-deficiency (PMM2-CDG)
por: Serrano, Natalia Lourdes, et al.
Publicado: (2017)

Identification through exome sequencing of the first PMM2-CDG individual of Mexican mestizo origin
por: González-Domínguez, C.A., et al.
Publicado: (2020)

Stroke-Like Episodes in PMM2-CDG: When the Lack of Other Evidence Is the Only Evidence
por: Serrano, Mercedes
Publicado: (2021)

Inappropriate cathepsin K secretion promotes its enzymatic activation driving heart and valve malformation
por: Lu, Po-Nien, et al.
Publicado: (2020)

The Analysis of Variants in the General Population Reveals That PMM2 Is Extremely Tolerant to Missense Mutations and That Diagnosis of PMM2-CDG Can Benefit from the Identification of Modifiers
por: Citro, Valentina, et al.
Publicado: (2018)

Correction: Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG)
por: García-López, Roberto, et al.
Publicado: (2016)

The Role of Hematopoietic Cell Transplant in the Glycoprotein Diseases
por: Naumchik, Brianna M., et al.
Publicado: (2020)

Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy
por: Izquierdo-Serra, Mercè, et al.
Publicado: (2018)

Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG
por: Iyer, Sangeetha, et al.
Publicado: (2019)

Non-functional alternative splicing caused by a Latino pathogenic variant in a case of PMM2-CDG
por: González-Domínguez, C.A., et al.
Publicado: (2021)

Factor XII in PMM2-CDG patients: role of N-glycosylation in the secretion and function of the first element of the contact pathway
por: López-Gálvez, Raquel, et al.
Publicado: (2020)

TGF-β Regulates Cathepsin Activation during Normal and Pathogenic Development
por: Flanagan-Steet, Heather, et al.
Publicado: (2018)

Severe multisystem pathology, metabolic acidosis, mitochondrial dysfunction, and early death associated with an X-linked AIFM1 variant
por: Moss, Tonya, et al.
Publicado: (2021)

A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG
por: Citro, Valentina, et al.
Publicado: (2017)

Fatal outcome after heart surgery in PMM2-CDG due to a rare homozygous gene variant with double effects
por: Görlacher, Marlen, et al.
Publicado: (2020)

D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trial
por: Witters, Peter, et al.
Publicado: (2021)

PMM2 -CDG T237M Mutation in a Patient with Cerebral Palsy-Like Phenotypes Reported from South India
por: Sreedevi, N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tnsrqtdf5kb3a5fn49eb2td15j